Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

89Bio Inc (NQ: ETNB )

20.16 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 7, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 19.50 (2)
Ask (Size) 20.30 (2)
Prev. Close 20.16
Today's Range 20.16 - 20.16
52wk Range 2.910 - 20.85
Shares Outstanding 72,868,455
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From 89bio, Inc.
Via GlobeNewswire
89bio Announces Late-Breaker Oral Presentation of Data from the Phase 2 ENLIVEN Study of Pegozafermin at EASL International Liver Congress 2023
From 89bio, Inc.
Via GlobeNewswire

Performance

YTD
+68.42%
+68.42%
1 Month
+15.86%
+15.86%
3 Month
+51.24%
+51.24%
6 Month
+141.44%
+141.44%
1 Year
+430.53%
+430.53%

More News

Read More
89bio Initiates Phase 3 ENTRUST Trial of Pegozafermin in Patients with Severe Hypertriglyceridemia (SHTG)
From 89bio, Inc.
Via GlobeNewswire
Analyst Ratings for 89bio
Via Benzinga
3 Biotech Buyout Targets to Watch
Via The Motley Fool
89bio Inc. (NASDAQ: ETNB) is a Stock Spotlight on 4/19
Via Investor Brand Network
89bio Reports First Quarter 2023 Financial Results and Provides Corporate Update
From 89bio, Inc.
Via GlobeNewswire
89bio to Participate in Upcoming Investor Conferences
From 89bio, Inc.
Via GlobeNewswire
89bio Inc. (NASDAQ: ETNB) is a Stock Spotlight on 4/10
Via Investor Brand Network
89Bio Inc. (NASDAQ: ETNB) is a Stock Spotlight on 3/31
Via Investor Brand Network
Over $40M Bet On 89bio? Check Out These 3 Stocks Insiders Are Buying
Via Benzinga
89Bio Inc. (NASDAQ: ETNB) Records 52-Week High Friday Morning
Via Investor Brand Network
Why Shares of 89bio Soared This Week
Via The Motley Fool
89Bio Inc. (NASDAQ: ETNB) Near the Top of Equities by Percentage Gain on 3/22
Via Investor Brand Network
89bio, Inc. Announces Upsized Pricing of $275 Million Public Offering of Common Stock
From 89bio, Inc.
Via GlobeNewswire
Why Block Shares Are Trading Lower By Over 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
KB Home, Accenture, Netflix And Other Big Stocks Moving Higher On Thursday
Via Benzinga
89bio To Rally 265%? Here Are 10 Other Analyst Forecasts For Thursday
Via Benzinga
89bio, Inc. Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants
From 89bio, Inc.
Via GlobeNewswire
Dow Rises 75 Points; Fed Increases Rates By 25bps
Via Benzinga
Why Edible Garden Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Why 89bio Shares Are Trading Higher Today
Via Benzinga
Nasdaq Edges Higher; Crude Oil Rises 1%
Via Benzinga
89bio (NASDAQ: ETNB) Reports Phase 2b ENLIVEN Trial of Pegozafermin Achieved Primary Endpoints For Treatment of Nonalcoholic Steatohepatitis (NASH)
Via Spotlight Growth
Exposures Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.